Peter Hovstadius M.D., Ph.D.

Peter Hovstadius M.D., Ph.D. Email and Phone Number

Stockholm, SE
Peter Hovstadius M.D., Ph.D.'s Location
Greater Stockholm Metropolitan Area, Sweden, Sweden
Peter Hovstadius M.D., Ph.D.'s Contact Details

Peter Hovstadius M.D., Ph.D. work email

Peter Hovstadius M.D., Ph.D. personal email

n/a
About Peter Hovstadius M.D., Ph.D.

With over 25 years in the Life Sciences sector, I have worked with both large multinational pharmaceutical companies and smaller biotech firms. As an MD, PhD, and strategic advisor, I've contributed to changes in medical departments across the Nordics by enhancing structures and performance.I have experience in interim senior medical roles and business coaching, working with both emerging and experienced leaders as well as biotech startups. I am passionate about fostering collaboration between medical and commercial departments to ensure these functions work effectively together.My approach is hands-on and results-focused. If you're interested in developing your pipeline, leadership, or business - let's connect.

Peter Hovstadius M.D., Ph.D.'s Current Company Details
The Swedish Association of the Pharmaceutical Industry, LIF

The Swedish Association Of The Pharmaceutical Industry, Lif

View
Chief Medical Officer
Stockholm, SE
Website:
lif.se
Employees:
64
Peter Hovstadius M.D., Ph.D. Work Experience Details
  • The Swedish Association Of The Pharmaceutical Industry, Lif
    Chief Medical Officer
    The Swedish Association Of The Pharmaceutical Industry, Lif
    Stockholm, Se
  • Lipum Ab
    Chief Medical Officer
    Lipum Ab Aug 2024 - Present
    Umeå, Västerbottens Län, Se
    Lipum AB (publ) is a clinical phase biopharmaceutical company specializing in the discovery and development of new treatments for chronic inflammatory diseases. The drug candidate SOL-116 is a humanized monoclonal antibody being evaluated to provide safer and more effective treatment by blocking a previously overlooked target molecule in the immune system, the Bile Salt-Stimulated Lipase (BSSL). SOL-116 is in clinical phase with compelling preclinical data for rheumatoid arthritis (RA). Lipum is also evaluating other inflammatory diseases with significant unmet medical needs.
  • Melker Of Sweden
    Member Board Of Directors And Investor
    Melker Of Sweden Mar 2024 - Present
    Huvudsta, Stockholm, Se
    At MELKER of Sweden, founded in 2015 by serial entrepreneur, innovator, and designer Pelle Stafshede, we set out with one bold ambition: to revolutionize the outdoor hardware industry.Our mission is built on a powerful interplay between the environment, ethics, and economy. We believe that through thoughtful innovation and responsible business practices, we can create products that make a genuine difference in the world.For us, sustainability is not just a buzzword but a guiding principle. We understand that all business activities come with an environmental footprint, from manufacturing to shipping. That’s why we are constantly refining our processes, striving for continuous improvement in everything we do. Sharing our journey with others, we aim to inspire positive change in the industry.At the heart of MELKER is a passion for creating high-quality, sustainable products designed for the long haul. Our innovation, design, and research are long-term investments—not only for our company but for future generations and the preservation of our planet.And it’s not just about the work. One of our core values is ensuring that we have fun along the way. Whether it's working with friends, family, or partners who share our philosophy, we believe that staying true to what we love is what makes MELKER a company we’re proud to be part of.
  • Ki Innovations Ab
    Business Coach
    Ki Innovations Ab Sep 2022 - Present
    Solna, Stockholm County, Se
    As an external business coach with KI Innovations, I bridge the gap between groundbreaking life science research and the business world. I guide startups from concept to commercialization, offering strategic advice, industry insights, and practical tools for success.Leveraging KI Innovations' network and expertise, I provide tailored, hands-on support to each startup. Through personalized coaching, workshops, and mentorship, I help founders refine their business models, strategize for market entry, and navigate the challenges of scaling up.I also connect startups with essential resources—investors, industry experts, and partners—while guiding them through regulatory, IP, and funding strategies. My goal is to empower founders to turn innovative ideas into impactful businesses, ensuring that their research makes a real difference in health and care.
  • Hovstadius Life And Science
    Life Science Leadership And Business Coach
    Hovstadius Life And Science Jun 2021 - Present
    As the Founder of Hovstadius Life & Science AB, my mission is to enhance leadership skills and business performance in the Life Science domain. The name "Life & Science" embodies my belief that true success stems from harmonizing these two elements.On the "science" front, I am committed to rigorous discovery and innovation, constantly pushing the boundaries of what is possible. However, I believe that scientific achievements can only reach their full potential when combined with the "life" aspect—a focus on personal happiness, fulfillment, and growth. It's not just about making breakthroughs in the lab; it's about ensuring those breakthroughs are driven by individuals who are well-rounded, compassionate, and fulfilled in their personal lives.I provide personal and business coaching, workshops, and speaking engagements, all aimed at helping individuals and organizations in the Life Sciences sector thrive by achieving this crucial balance.
  • Xnk Therapeutics
    Chief Medical Officer
    Xnk Therapeutics Dec 2022 - Apr 2024
    At XNK Therapeutics, we're pioneering advancements in biotechnology by developing cutting-edge immunotherapies for cancer treatment. In my role, I lead both the operational and strategic facets of our clinical trials and regulatory affairs, ensuring that our innovative therapies successfully reach the market. Additionally, I play a key role in business development, forging strategic partnerships and collaborations that amplify our mission and extend our impact in the healthcare industry.
  • Inex One
    Member Of Board And Investor
    Inex One Aug 2019 - May 2022
    Stockholm, Stockholm County, Se
    Inex One is a platform that brings together the world’s top expert networks and survey providers, allowing businesses to access a wide range of expertise through a single dashboard. As an early investor and former board member, I contributed to the strategic direction and growth of the company, helping to establish its position as a leader in the expert network industry.
  • Novartis
    Chief Innovation Officer Nordics
    Novartis Mar 2020 - Jun 2021
    Basel, Baselstadt, Ch
    As the founder of the Novartis Innovation Office, I established and led innovative collaborations that significantly drove the success of Novartis products across the healthcare space. My work focused on accelerating innovation and harnessing the full potential of digital transformation, ensuring that Novartis products effectively addressed unmet medical needs. By scouting and partnering with digital health startups, I facilitated strategic business development initiatives that enhanced our product offerings and expanded our impact in the healthcare industry.
  • Novartis
    Chief Scientific Officer Nordics
    Novartis Sep 2012 - Mar 2020
    Basel, Baselstadt, Ch
    As Chief Medical Officer, I led the clinical trial operations (Phases I-IV), Medical Affairs, Regulatory Affairs, and Pharmacovigilance departments. One of my key achievements was expanding the cross-Nordic Medical Affairs department from 12 to 70 employees within three years, which was instrumental in enhancing the development and successful launch of our pharmaceutical products across the Nordic region. Additionally, I provided strategic guidance as a member of the Pharma Executive Committee and the European Medical Leadership Team, driving the success of our clinical and medical initiatives.
  • Lif - De Forskande Läkemedelsföretagen
    Chairman, Medical Council
    Lif - De Forskande Läkemedelsföretagen Jan 2018 - Mar 2020
    Stockholm, Se
    As Chairman of the Medical Council at Läkemedelsindustriföreningen (LIF), I led a council composed of the medical directors from the largest pharmaceutical companies in Sweden. LIF is the trade association for the research-based pharmaceutical industry in Sweden, representing around 90 member and associate companies. My role involved guiding the council in addressing critical medical and regulatory issues that affect the pharmaceutical industry, fostering collaboration among top industry leaders.In this capacity, I played a key role in shaping the collective medical strategy for the industry, ensuring that the voices of Sweden's leading pharmaceutical companies were effectively represented.
  • Merck Sharp & Dohme
    Associate Director Medical Affairs
    Merck Sharp & Dohme Mar 2010 - Sep 2012
    Immunology Unit (Rheumatology/Dermatology): I managed investigator relations, oversaw Advisory Boards, and led Investigator-Initiated Studies. Additionally, I played a key role in establishing disease registries and spearheaded an online education initiative, culminating in the creation of www.msdplay.se. This platform was designed to enhance knowledge sharing and support ongoing education in the field of immunology.
  • Merck Sharp & Dohme
    Research Director
    Merck Sharp & Dohme 2007 - Mar 2010
    Oversaw feasibility, implementation and conduct of Merck clinical study protocols in Sweden. Planned and executed the regional research strategy. Tactical assessment of country capability, including analysis of competitive landscape and collaboration with business development.
  • Roche Pharmaceuticals
    Country Medical Manager
    Roche Pharmaceuticals 2005 - 2007
    Switzerland 🇨🇭 , Ch
    Responsible for data generation and dissemination on marketed and development compounds. Advisory Boards, congresses, investigator meetings, protocol development and more. Lectured extensively internally and externally (oncology and oncology trials).
  • Uppsala Universitet
    Director Of Studies, Clinical Drug Development
    Uppsala Universitet 2002 - 2006
    Uppsala, Uppsala Län, Se
    Planned, coordinated and participated as a teacher in a post graduate course in clinical drug development at Uppsala University. The curriculum covered all aspects of drug development: preclinical research with target identification to finalization of phase III studies.https://www.ucr.uu.se/sv/utbildning/cdd-kurs
  • Akademiska Sjukhuset
    Residency In Clinical Pharmacology / Oncology
    Akademiska Sjukhuset 1998 - 2002
    Uppsala, Se
    During my residency in Clinical Pharmacology, I was deeply involved in several key areas that are central to the specialty. I focused on rational drug use, ensuring that medications were prescribed based on the best available evidence to optimize patient outcomes. I also gained significant experience in toxicology and therapeutic drug monitoring, essential for managing and understanding the safety and efficacy of drug therapies.My role included active participation in the Hospital Drugs and Formulary Committee, where I contributed to decisions regarding the selection and use of medications within the hospital. I was involved in monitoring adverse drug reactions, a critical aspect of ensuring patient safety, and provided clinical consultation services to guide therapeutic decisions.Additionally, I conducted research as an investigator in clinical trials, contributing to the development of new treatments. My training also included a sub-specialty focus in Clinical Oncology, further enhancing my ability to integrate pharmacological principles into cancer care.This comprehensive training prepared me to bridge the gap between the science of pharmacology and its application in clinical practice, ultimately improving patient care through the safe and effective use of medications​
  • Janssen-Cilag
    Project Manager
    Janssen-Cilag 1996 - 1998
    Raritan, New Jersey, Us
    Overall responsible at a country level for initiation, running and close out of clinical trials. Including site level activities - monitoring, GCP education for Investigators and contract negotiations.
  • Region Sörmland
    Physician, Internship
    Region Sörmland 1994 - 1996
    Nyköping, Sörmland, Se
    During my internship training (AT-tjänst) to become a licensed physician, I gained comprehensive experience across multiple medical disciplines. This included rotations in Internal Medicine, where I managed a variety of complex medical conditions; Surgery, where I developed hands-on skills in both elective and emergency procedures; Psychiatry, where I provided care for patients with mental health disorders; and General Medicine, where I honed my skills in primary care, addressing a broad spectrum of health issues. This diverse training equipped me with a solid foundation in patient care across multiple specialties.
  • Friluftsmagasinet
    Founder Owner
    Friluftsmagasinet Jan 1989 - Jan 1993
    I founded and managed a retail outdoor and adventure store in Uppsala, Sweden, where I handled all aspects of business development, including finance and budgeting, contract negotiations, product purchasing, and advertising. I also recruited, trained, and supervised a team of 8 sales staff. After successfully running the store for four years, it was sold to a company that eventually became Naturkompaniet, a leading retailer in outdoor gear and apparel in Sweden.

Peter Hovstadius M.D., Ph.D. Skills

Clinical Development Clinical Trials Medical Affairs Gcp Drug Development Pharmaceutical Industry Clinical Research Therapeutic Areas Pharmacovigilance Drug Safety Clinical Pharmacology Oncology Immunology Medicine Medical Writing Lifesciences Clinical Study Design Internal Medicine Change Management Pharmacology Coaching Psychiatry Protocol Biotechnology

Peter Hovstadius M.D., Ph.D. Education Details

  • Uppsala University
    Uppsala University
    Drug Development
  • Uppsala University
    Uppsala University
    Medicine
  • Uppsala University
    Uppsala University
    Master'S Programme In Engineering Physics
  • Kth Royal Institute Of Technology
    Kth Royal Institute Of Technology
    Mathematics And Physics

Frequently Asked Questions about Peter Hovstadius M.D., Ph.D.

What company does Peter Hovstadius M.D., Ph.D. work for?

Peter Hovstadius M.D., Ph.D. works for The Swedish Association Of The Pharmaceutical Industry, Lif

What is Peter Hovstadius M.D., Ph.D.'s role at the current company?

Peter Hovstadius M.D., Ph.D.'s current role is Chief Medical Officer.

What is Peter Hovstadius M.D., Ph.D.'s email address?

Peter Hovstadius M.D., Ph.D.'s email address is pe****@****ius.com

What schools did Peter Hovstadius M.D., Ph.D. attend?

Peter Hovstadius M.D., Ph.D. attended Uppsala University, Uppsala University, Uppsala University, Kth Royal Institute Of Technology.

What skills is Peter Hovstadius M.D., Ph.D. known for?

Peter Hovstadius M.D., Ph.D. has skills like Clinical Development, Clinical Trials, Medical Affairs, Gcp, Drug Development, Pharmaceutical Industry, Clinical Research, Therapeutic Areas, Pharmacovigilance, Drug Safety, Clinical Pharmacology, Oncology.

Who are Peter Hovstadius M.D., Ph.D.'s colleagues?

Peter Hovstadius M.D., Ph.D.'s colleagues are Sophia Brodin, Anton Hübner, Erik Kjellin, Vilda Henley, Helena Ek, Lama Albakri, Ulrika Unger.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.